Symbiomix announced positive results from the second pivotal Phase 3 trial of SYM-1219 (secnidazole) for the treatment of bacterial vaginosis (BV).
Prolactin receptor (PRLR) signaling plays a role in expansion of maternal β-cells during pregnancy, according to a study published online in Diabetes.
In the most definitive study to date, cigarette smoking during pregnancy was linked to a greater likelihood of schizophrenia in offspring. Those are the findings of a new long-term study which assessed maternal nicotine exposure (via cotinine levels) during pregnancy.
Researchers from Johns Hopkins Bloomberg School of Public Health reported that too much folate in a new mother's body may increase a child's risk of developing an autism spectrum disorder. Findings from the study will be presented at the 2016 International Meeting for Autism Research.
An updated Cochrane review found low or very low quality evidence.
Lupin Pharmaceuticals has announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH).
The Food and Drug Administration (FDA) is advising caution when prescribing oral fluconazole (Diflucan) in pregnancy after evaluating data from a Danish study that indicated a possible increased risk of miscarriage when used to treat yeast infections.
Hospira announced a voluntary recall of one lot of 50% Magnesium Sulfate Injection, 10g/20mL (0.5/gmL), 20mL single-dose vials.
A Cochrane review found no high quality evidence to support the efficacy of any dietary supplement for dysmenorrhea.
According to a study published in Neurology, babies born to pregnant women taking lamotrigine may not be at an increased risk of birth defects, such as a cleft lip, cleft palate or clubfoot.
The Society for Maternal-Fetal Medicine (SMFM) issued a statement on the use of antenatal corticosteroids during the late preterm birth period for women at risk of preterm birth.
Selective serotonin reuptake inhibitors (SSRIs) use during pregnancy and lactation can result in decreased bone density in mothers, increasing their risk of fractures later in life, a study presented at ENDO 2016 has found.
Polycystic ovary syndrome (PCOS) and excess weight have been independently linked with the onset of asthma, according to findings in a new study to be presented at the annual Endocrine Society meeting.
Radius Health announced the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA) for abaloparatide-subcutaneous (SC) 80mg, a once daily treatment for postmenopausal women with osteoporosis.
The Endocrine Society has issued a statement advising clinicians to avoid administering compounded hormone medications to treat menopausal symptoms, female sexual dysfunction, and other hormone conditions.
Expecting mothers should make sure they get enough vitamin D exposure during the second trimester to reduce the child's likelihood of developing asthma, according to new research by the University of Kansas published in the American Journal of Health Economics.
Researchers from Western Australia reported that seasonal influenza vaccinations may protect against stillbirth.
Drugs that were once considered safe for pregnant women with migraines may not be, according to researcher at Wake Forest Baptist Medical Center.
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Mifeprex (mifepristone; Danco Laboratories) including modifications to the risk evaluation and mitigation strategy (REMS) assessment.
Researchers from the National Institutes of Health and Ohio State University report that the risk of miscarriage increases if couples consume over two caffeinated beverages a day in the weeks leading up to conception.
In women who use oral contraceptives, obesity is a strong risk factor for cerebral venous thrombosis.
Strides are being made toward the development of a male oral contraceptive. Researchers at the University of Minnesota are making tweaks to experimental compounds already developed by the drug company Bristol-Myers Squibb (BMS), to produce a safe, soluble and fast-acting male contraceptive.
Duchesnay announced the launch of Mteryti and Mteryti folic 5 products to help optimize iron, calcium, and folic acid absorption for prenatal use.
In a new draft guidance, the Food and Drug Administration (FDA) announced that they have ordered Bayer to conduct follow-up studies for their permanent form of birth control, Essure.
How safe and effective is flibanserin (Addyi; Valeant) for the treatment of hypoactive sexual desire disorder (HSDD) in women?
A new review article explores the current research findings of perimenopausal women's symptoms and the treatment options available to reduce the impact they may have on quality of life.
Vertical Pharmaceuticals announced the launch of OB Complete Gold, prenatal vitamins providing the first egg-based docosahexaenoic acid (DHA).
Infants whose mothers took atazanavir had small but significant effects on language and social-emotional development, compared to other non-atazanavir-containing antiretroviral regimens, a study published in AIDS has shown.
A study found that 30% of women with epilepsy did not use highly effective contraception though they are at an increased risk of having babies with fetal malformations due to their antiepileptic medications.
AbbVie and Neurocrine Biosciences announced positive top-line results from the second of two replicate Phase 3 clinical trials of Elagolix in premenopausal women with endometriosis-associated pain.
Serologic testing for Zika virus has been recommended in asymptomatic pregnant women, who have traveled to, or reside in, areas of ongoing transmission.
Authors of a new study argue their findings provide sufficient evidence to change standard skin-prep practices for C-sections, in order to avoid the ongoing risk of infection.
Early treatment with oseltamivir may reduce length of hospital stay for pregnant women with the flu, especially for severe cases, a new study reported.
The U.S. Centers for Disease Control and Prevention (CDC) has called for an increase in research on the potential risks of taking antidepressants during pregnancy.
Two new trials have found no significant statistical reduction in cases of persistent wheezing and asthma where the mother had taken additional vitamin D supplements.
Taking certain asthma medication during pregnancy could increase the risk of the child being diagnosed with autism spectrum disorder.
A new study has found that women who take oral contraceptives just before or during pregnancy do not have an increased risk of birth defects.
Using the oral antifungal medication fluconazole during pregnancy has been associated with an increased risk of spontaneous abortion.
Hospira announced a voluntary recall of one lot of Magnesium Sulfate in Water for Injection (0.235mEq Mg/mL) 40mg/mL 2g total, 50mL due to a potentially incorrect barcode.
Using the antidepressant paroxetine during the first trimester of pregnancy may increase the risk of major congenital and cardiac malformations in newborns.
Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments.
Metformin may potentially help prevent and treat preeclampsia, according to a study published in the American Journal of Obstetrics and Gynecology.
A large-scale study has found a link between antidepressant (AD) use during the second and/or third trimester of pregnancy and an increased risk of autism spectrum disorder (ASD) in children by 87%.
Young males whose mothers smoked during pregnancy had lower aerobic fitness compared to males whose mothers did not smoke, according to a study published in BJOG: an International Journal of Obstetrics and Gynaecology.
A Phase 3 Rejoice Trial of TX-004HR (estradiol) to treat moderate to severe dyspareunia (vaginal pain during sexual intercourse), has had positive top-line results.
A Phase 2 clinical trial has shown how the pregnancy hormone estriol can help patients with relapsing-remitting multiple sclerosis (RRMS) avoid relapses.
The United States Preventive Services Task Force (USPSTF) released its annual Report to Congress reporting on 5 high-priority evidence gaps regarding women's health.
Healthy weight management before getting pregnant and appropriate weight gain during pregnancy significantly reduce the risk of infant death.
Compared to those who had not been on oral contraceptives, patients who had taken the pill had improved progression-free survival as well as overall survival.
A new study has found that the two most commonly prescribed antibiotics are not associated with an increased risk of adverse outcomes in pregnant women.
Ob-Gyns may help lower unintended pregnancy rates by increasing access to contraceptive implants and intrauterine devices (IUDs) for patients, according to a Committee Opinion paper released by ACOG.
The American Academy of Pediatrics (AAP) has issued a new clinical report in the November issue of Pediatrics emphasizing that no amount of alcohol should be considered safe to drink during any trimester of pregnancy due to the risk of fetal alcohol spectrum disorders (FASDs).
Sprout announced that that Addyi (flibanserin) tablets are now available for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Research in the American Society for Microbiology's journal Antimicrobial Agents and Chemotherapy found that pregnant women taking antiviral medications to treat hepatitis C (HCV) and/or HIV with non-steroidal anti-inflammatories (NSAIDs) or antihypertensives may have an increased risk of birth defects or stunted fetal growth, although these antiviral drugs have not been shown to directly cause harm to a fetus.
A new clinical practice guideline has been issued by the Endocrine Society on the treatment of menopausal symptoms.
As more states implement specific Medicaid reimbursement practices for immediate postpartum long-acting reversible contraception (LARC) such as intrauterine devices (IUDs) and implants, researchers from the University of Michigan Health System have identified challenges for agencies and providers alike in a study published in Contraception.
According to a National Institutes of Health (NIH) Study, infants exposed in the womb to the HIV drug tenofovir disoproxil fumarate, may have lower bone mineral content than those exposed to other anti-HIV drugs.
Research presented at the 2015 Annual Meeting of The North American Menopause Society (NAMS) supports previous findings that use of local estrogens for genitourinary symptoms of menopause (vaginal dryness, painful intercourse, and urinary tract infections) are underutilized, but the study also reports that method of local treatment can impact treatment duration and adherence to therapeutic guidelines.
A pilot study in the Journal of the American Society of Nephrology outlines one of the first therapeutic interventions for preeclampsia that could allow women to safely prolong their pregnancy via removal of soluble Fms-like tyrosine kinase-1 (sFlt-1) from the blood via apheresis.
Bayer HealthCare announced that a recent Food and Drug Administration (FDA) Advisory Committee met to review and discuss data regarding the benefits and risks associated with use of the Essure medical device for hysteroscopic sterilization.
An updated report in MedLink Neurology stated that oral contraceptives are associated with a small but significant increase in ischemic stroke risk, particularly for women who smoke, have hypertension, or a history of migraine headaches.
Placental vascular disorders during early pregnancy is associated with increased risk of developing serious obstetric complications, a study from The American Journal of Pathology reported.
A flavonoid commonly found in fruits and vegetables shows promise in reducing the risk of breast cancer in postmenopausal women, according to new research published in Springer Plus.
An in-depth review of the safety and efficacy of treatments for premenstrual dysphoric disorder (PMDD) has been published in the Journal of Psychiatric Practice.
The Food and Drug Administration (FDA) has granted SYM-1219 (secnidazole, Symbiomix) Fast Track designation for the treatment of bacterial vaginosis (BV).
Based on a new study published in Neurology, researchers have developed the first clinical recommendations for making diagnostic decisions regarding headaches in pregnant women.
The Food and Drug Administration (FDA) has approved Addyi (flibanserin) for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.
Significantly different microbiomes were seen in the reproductive tracts of pregnant women who had a baby born prematurely vs. women who delivered full term.
Cycle Technologies announced the launch of Dot, a period-tracking and fertility app to evaluate a woman's risk of pregnancy for each day of her cycle.
Women who conceive following in vitro fertilization (IVF) are significantly more likely to develop gastroesophageal reflux disease (GERD) at least one year after delivery, although the risk does not vary with singleton and twin births, according to a study in the United European Gastroenterology Journal.
A new study in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) suggests that imaging studies used to diagnose traumatic injuries sustained by pregnant women are safe when used properly.
Results from a cohort study evaluating over one million pregnant women enrolled in Medicaid revealed that nitrofurantoin was the most commonly dispensed medication during pregnancy.
Contrary to prior research, a study appearing in Obstetrics & Gynecology reports no increased risk of seizures in neonates born to mothers exposed to calcium channel blockers (CCBs) in late pregnancy.
An analysis has found that using oral contraceptives for even a few years can give long-term protection against endometrial cancer, showing greater risk reduction with longer use.
The use of selective serotonin reuptake inhibitors (SSRIs) to treat maternal psychiatric disorders was linked to a lower risk of preterm birth and a delivery but a higher risk of neonatal problems.
Postmenopausal women did not experience beneficial effects on bone mineral density, muscle function, muscle mass or falls with high-dose vitamin D, according to a study published in JAMA Internal Medicine.
Many new mothers do not receive advice from clinicians on infant care or receive advice from healthcare professionals or family members that is not consistent with recommendations and guidelines, reports a new study in Pediatrics.
Use of emergency contraception by female teenagers has increased over the past decade while the percentage of both male and female teenagers who have had sexual intercourse has decline since 1988, according to new data from the Centers for Disease Control and Prevention's (CDC) National Center for Health Statistics (NCHS).
An investigational drug to treat hot flashes and other menopausal symptoms selectively delivers estrogen only to the brain, sparing other organs from hormone exposure and potential side effects.
A baby's first stool may indicate that the child could have difficulty in cognitive development, new research from the Case Western Reserve University Project Newborn has shown.
Giving antidiabetic drugs to obese pregnant women may not prevent their babies from being born overweight, according to a study published in The Lancet Diabetes and Endocrinology.
A study in BMJ reports that an increased risk of birth defects was seen with use of some selective serotonin reuptake inhibitors (SSRIs) during early pregnancy, but that the absolute risk is still low if the association is indeed causal.
HPSRx announced the launch of Caya, a non-hormonal contoured diaphragm for use as a female contraceptive barrier device for up to two years.
A significant drop in out-of-pocket spending for oral contraceptives and intrauterine devices (IUDs) has been evident since the Affordable Care Act (ACA) went into effect, according to a study published in Health Affairs.
Bayer HealthCare announced that the Food and Drug Administration (FDA) has approved an alternate confirmation test for Essure inserts, administered three months following the procedure for hysteroscopic sterilization.
There appears to be a difference in contraception use among female adolescents based on weight, as new research appearing in the Journal of Pediatrics found that sexually active obese adolescents were significantly less likely to use contraception compared to their normal weight peers.
The Food and Drug Administration (FDA) has approved Tri-Lo-Estarylla (ethinyl estradiol, norgestimate; Sandoz) tablets for oral contraception.
Children who were born via cesarean section delivery were 21 percent more likely to be diagnosed with autism spectrum disorder (ASD) but this link was not found to be causal upon further analysis of sibling pairs, new research has found.
The PeriCoach System is now available to strength and tone pelvic muscles in women with urinary incontinence following its approval in March 2015.
A computer model predicts that offering women immediate postpartum etonogestrel implant insertion could be extremely cost-effective for both new mothers and medical insurance companies.
A drug indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and binge eating disorder also helped women with executive functions related to menopause in research appearing in the journal Psychopharmacology.
A study presented at the European League Against Rheumatism Annual Congress (EULAR 2015) indicates that use of some non-steroidal anti-inflammatory drugs (NSAIDs) could have a negative impact on female fertility, even with short-term use.
Interest in potential health benefits with consuming the placenta postpartum has increased in recent years, but a review in the Archives of Women's Mental Health found inconclusive data on the perceived health benefits with placentophagy.
The Food and Drug Administration (FDA) Advisory Committee has voted 18-6 in favor of approving flibanserin, an investigational agent for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women if certain risk management options beyond labeling are implemented.
While a new study appearing in the Journal of the American Medical Association suggests that use of antidepressants in late pregnancy may be associated with an increased risk of persistent pulmonary hypertension of the newborn (PPHN), the absolute risk is small and the risk increase appears to be less than previous studies have suggested.
Research published in Clinical Gastroenterology and Hepatology showed that nearly all pregnant women with hepatitis B virus (HBV) taking telbivudine had undetectable levels of HBV DNA in cord blood, with no severe adverse events or complications observed in women or infants.
Vitamin D and calcium supplements do not appear to reduce menopausal symptoms in older women, reports a new study published in Maturitas, the official journal of the European Menopause and Andropause Society.
Prolonged acetaminophen use (1 week) by pregnant women may suppress fetal testosterone production, according to researchers from the University of Edinburgh.
A new study in JAMA reports that a significant reduction in the rate of dispensing of codeine to postpartum women was observed following public health advisories from the U.S. Food and Drug Administration (FDA) and Health Canada on potentially life-threatening adverse effects in infants of breastfeeding mothers taking codeine.
A study by the Centers for Disease Control and Prevention (CDC) and Cedars-Sinai proposes that the 9-valent human papillomavirus (HPV) vaccine could prevent 80 percent of cervical cancers in the United States if administered to all 11- or 12-year-old children prior to exposure to the virus.